Top News: #Diabetes

Here are the top read news for #Diabetes:


actosType 2 Diabetes Drug Actos Linked To Increased Risk Of Bladder Cancer, But Not Avandia:

Pioglitazone, sold under the brand name Actos and prescribed for patients with Type 2 diabetes, is linked to an increased risk of bladder cancer, according to a team of Canadian researchers. This risk increases the longer it’s taken and the higher the dosage, their new study suggests. Importantly, the researchers discovered rosiglitazone, a similar diabetes drug sold under the trade name Avandia, did not increase the risk of bladder cancer: Read more

 


diabetesmedsDiabetes meds vary in safety and effectiveness, study shows:

A study of nearly a half-million people with type 2 diabetes shows there are pros and cons to nearly every form of drug therapy for the disease. In the British study, researchers looked at patient outcomes from a large U.K. database of almost 470,000 adults with type 2 diabetes, tracked between 2007 and 2015. Julia Hippisley-Cox and Carol Coupland, of the University of Nottingham, sought to parse out differences among a variety of diabetes drugs: Read more

 


31UP-health-Diabetes-1-master675The Quiet Research That Led to a Resounding Success in Diabetes Prevention:

More than 86 million people, including 22 million people 65 or older, have pre-diabetes, which increases their risk of heart disease, strokes or diabetes. As we’ve watched that number grow, it has somehow felt that despite billions of dollars of research and intervention, there’s little we can do. That feeling shifted last week when Sylvia Mathews Burwell, the secretary of health and human services, announced that Medicare was planning to pay for lifestyle interventions focusing on diet and physical activity to prevent Type 2 diabetes. It’s an example of small-scale research efforts into health services that have worked and that have expanded to reach more people: Read more

Advertisements